Printer Friendly

PHARMACEUTICAL BASICS VOLUNTARILY RECALLS DRUG

 PHARMACEUTICAL BASICS VOLUNTARILY RECALLS DRUG
 MORTON GROVE, Ill., June 12 /PRNewswire/ -- Pharmaceutical Basics,


Inc. (PBI) of Morton Grove, Ill., in cooperation with the Food and Drug Administration, is voluntarily recalling all lots of Metaproterenol Sulfate Inhalation Solution, USP five percent having an expiration date later than May 1, 1992. Metaproterenol Sulfate Inhalation Solution, USP five percent is a prescription drug dispensed to patients with bronchial asthma or experiencing reversible bronchospasm associated with bronchitis or emphysema. The recall is being conducted as a result of routine testing by PBI, which disclosed the presence of microbial growth exceeding specified limits in certain lots, e.g., Pseudomonas gladioli/cepacia. The recall applies to all unexpired lots even though excessive microbial growth has been confirmed only in limited lots. The recalled PBI lots were marketed under the labels of the following companies: Dey Laboratories, Inc.; Goldline Laboratories; H.L. Moore; Qualitest Products, Inc.; Pharmaceutical Basics, Inc.; and Rugby Laboratories, Inc.
 The product was distributed nationwide and the estimated quantity remaining on the market is approximately 16,000 units.
 Metaproterenol Sulfate Inhalation Solution, USP five percent, is clear to pale yellow in color, and the dropper is graduated showing 0.2 and 0.3 ml black lines.
 The presence of excessive microbial growth in Metaproterenol Sulfate Inhalation Solution, USP five percent poses a risk of potential serious pulmonary infections to all patients for whom the drug would be prescribed. The FDA has determined that this situation represents a particularly serious heath hazard, which may be life-threatening, to patients with chronic obstructive airway disease, with cystic fibrosis (CF), or with compromised immune systems.
 PBI is requesting all pharmacists to review their dispensing records for the period April 1, 1992 to the present and to notify any patient dispensed any of the recalled lots to immediately contact their physician regarding a replacement medication.
 PBI requests all patients who have any of this product from a lot having an expiration date later than May 1, 1992, whether or not they have been contacted by a pharmacist, to immediately consult their physician regarding a replacement medication. Patients should promptly return the recalled Metaproterenol Sulfate Inhalation Solution, USP five percent to their pharmacist.
 -0- 6/12/92
 /CONTACT: Pharmaceutical Basics, Inc., 1-800-445-8091, or 312-380-0080/ CO: Pharmaceutical Basics, Inc. ST: Illinois IN: MTC SU:


TQ-LR -- NY084 -- 9901 06/12/92 19:06 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 12, 1992
Words:392
Previous Article:METRO-GOLDWYN-MAYER TO PAY INTEREST ON NOTES, DEBENTURES
Next Article:SEARS REAFFIRMS CUSTOMER GUARANTEE
Topics:


Related Articles
PAR PHARMACEUTICAL AND SUBSIDIARY REQUEST FDA TO WITHDRAW APPLICATIONS
DRUG RECALL BY PHARMACEUTICAL BASICS
WARNER-LAMBERT VOLUNTARILY RECALLING SELECT DRUGS FROM DIRECT ACCOUNTS
COPLEY PHARMACEUTICAL, INC. ANNOUNCES ESTIMATED ALBUTEROL RECALL EXPENSES
COPLEY PHARMACEUTICAL REPORTS ON INVESTIGATION OF ASTHMA PRODUCT RECALL
COPLEY PHARMACEUTICAL REPORTS ON INVESTIGATION OF ASTHMA PRODUCT RECALL
FDA ANNOUNCES RECALL OF METERED DOSE INHALER
Ciba Pharmaceuticals States Branded Tegretol Not Affected By Recall
One lot of Neurontin recalled.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters